Combined with your current HbA1c, weight-loss trajectory, and tolerance profile, genetic context helps build a personalized treatment plan rather than a one-size-fits-all approach
Telogen effluvium: A comprehensive review
The inhibitory activity of cocoa phenolic extract against pro-inflammatory mediators secretion induced by lipopolysaccharide in RAW 264.7 cells
The ESSENCE data may represent key findings for patients in the treatment of MASH, which is estimated to affect about one in 20 adults in the U.S. Of those on semaglutide, 63% of participants experienced a reduction in liver inflammation without worsening scarring, compared to only 34% in the placebo group
Magge is a member of the National Institutes of Health Human Studies of Diabetes and Obesity Study Section
A Better Way Forward Lasting transformation begins with a strategy designed around the individual